Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on April 27, 2005
J Am Soc Nephrol 16: 1849-1858, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2004100836

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2004100836v1
16/6/1849    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hauser, I. A.
Right arrow Articles by Radeke, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hauser, I. A.
Right arrow Articles by Radeke, H. H.

Clinical Transplantation

Prediction of Acute Renal Allograft Rejection by Urinary Monokine Induced by IFN-{gamma} (MIG)

Ingeborg A. Hauser*, Sandra Spiegler{dagger}, Eva Kiss§, Stefan Gauer*, Olaf Sichler*, Ernst H. Scheuermann*, Hanns Ackermann{ddagger}, Josef M. Pfeilschifter{dagger}, Helmut Geiger*, Hermann-Josef Gröne§ and Heinfried H. Radeke{dagger}

* Medical Clinic IV, Nephrology; {dagger} The pharmazentrum frankfurt, Dr. Hans Schleussner Foundation, Immune Pharmacology; {ddagger} Department of Medical Informatics and Biomathematics, Clinic of the J.W. Goethe University, Frankfurt, Germany; and § Institute of Pathology, German Cancer Research Center (DKFZ), Heidelberg, Germany

Address correspondence to: Dr. Ingeborg A. Hauser, Medical Clinic IV, Department of Nephrology, Clinic of the J.W. Goethe University, Theodor-Stern-Kai 7, D-60590 Frankfurt, Germany. Phone: +49-696301-7864; Fax: +49-696301-7862; E-mail: i.hauser{at}em.uni-frankfurt.de; or Dr. Heinfried Radeke, Pharmazentrum Frankfurt, Dr. Hans Schleussner Foundation of Immune Pharmacology, Building 75, Room 103, Clinic of the J.W. Goethe University, Theodor-Stern-Kai 7, D-60590 Frankfurt, Germany. Phone: +49-696-3018-3104; Fax: +49-696-3018-3202; radeke{at}em.uni-frankfurt.de

Received for publication October 8, 2004. Accepted for publication March 14, 2005.

Early diagnosis of acute allograft rejection (AR) is still decisive for long-term renal allograft survival. The aim of this study was to define the role of the chemokine monokine induced by IFN-{gamma} (MIG) (CXCL9) and IFN-{gamma}–inducible protein 10 (IP-10) (CXCL10) as early markers of AR in renal transplantation (NTX). In a prospective study, 69 de novo renal transplant recipients were monitored and urine samples were collected after NTX for a median of 29 d. In pH-adjusted urine, MIG and IP-10 were determined by modified ELISA. AR was clinically diagnosed in 15 of 69 recipients and confirmed by biopsy in 14 of 15 AR patients (Banff classification). Corresponding to CXCR3-positive infiltrates in renal tissue, urinary MIG was elevated in 14 of 15 AR patients with a median of 2809 pg/ml (quartile 25% and 75% = 870 and 13,000; n = 15), being significantly (P < 0.0001) different from both nonrejecting allograft patients (NO-AR) (median, 25%, and 75%: 96, 1.0, and 161, n = 54) and healthy controls (median, 25%, and 75%: 144, 19, and 208, n = 13). Urinary MIG predicted AR with a sensitivity of 93% and a specificity of 89%. In AR and NO-AR groups, MIG values correlated well with IP-10 (P < 0.001). MIG values indicated both imminent rejection and response to successful antirejection therapy. MIG was not related to intercurrent infections or other causes for impairment of renal function. In a multivariate analysis, MIG correlated best (P < 0.001) with AR from all AR-associated parameters. In conclusion, urinary MIG serves as a very sensitive and specific predictor for AR, mirrors response to antirejection therapy, and thus may contribute to improved long-term renal allograft survival.




This article has been cited by other articles:


Home page
J. Virol.Home page
D. M. Brainard, A. M. Tager, J. Misdraji, N. Frahm, M. Lichterfeld, R. Draenert, C. Brander, B. D. Walker, and A. D. Luster
Decreased CXCR3+ CD8 T Cells in Advanced Human Immunodeficiency Virus Infection Suggest that a Homing Defect Contributes to Cytotoxic T-Lymphocyte Dysfunction
J. Virol., August 15, 2007; 81(16): 8439 - 8450.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
M. Rotondi, L. Chiovato, S. Romagnani, M. Serio, and P. Romagnani
Role of Chemokines in Endocrine Autoimmune Diseases
Endocr. Rev., August 1, 2007; 28(5): 492 - 520.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
O. M. Steinmetz, R. A. K. Stahl, and U. Panzer
Formation of lymphoid-like tissue in the kidney--is there a role for chemokines?
Nephrol. Dial. Transplant., February 1, 2007; 22(2): 350 - 352.
[Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
U. Hoffmann, S. Segerer, P. Rummele, B. Kruger, M. Pietrzyk, F. Hofstadter, B. Banas, and B. K. Kramer
Expression of the chemokine receptor CXCR3 in human renal allografts--a prospective study
Nephrol. Dial. Transplant., May 1, 2006; 21(5): 1373 - 1381.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP